Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Has results × Carmustine × Clear all

Phase

Phase 2 30 Phase 1/2 11 Phase 3 6 Phase NA 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 1 Hodgkin Disease 1

Interventions

Radiosurgery 47 Radiotherapy 41 Magnetic Resonance Spectroscopy 36 Cyclophosphamide 31 Standard of Care 25 Surveys and Questionnaires 20 Dexamethasone 19 Educational Status 18 Radiation 16 fludarabine phosphate 15 Mammography 15 Cisplatin 15 Methods 14 Magnetic Resonance Imaging 14 Doxorubicin 14 Therapeutics 13 Proton Therapy 13 Practice Guidelines as Topic 13 Fluorodeoxyglucose F18 13 Exercise 13 Calcium Dobesilate 13 Acupuncture Therapy 13 fludarabine 12 Indocyanine Green 12 Granulocyte Colony-Stimulating Factor 12 Filgrastim 12 Blood Specimen Collection 12 Surgical Procedures, Operative 11 Radiotherapy, Intensity-Modulated 11 Radiofrequency Ablation 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01702961 2018-12-19

Rituxan+BEAM

Baylor College of Medicine

Phase NA Completed

75 enrolled 8 charts

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡